Camouflage Nanoparticles Enable in Situ Bioluminescence-Driven Optogenetic Therapy of Retinoblastoma.

Optogenetic therapy has emerged as a promising technique for the treatment of ocular diseases; however, most optogenetic tools rely on external blue light to activate the photoswitch, whose relatively strong phototoxicity may induce retinal damage. Herein, we present the demonstration of camouflage nanoparticle-based vectors for in situ bioluminescence-driven optogenetic therapy of retinoblastoma. In biomimetic vectors, the photoreceptor CRY2 and its interacting partner CIB1 plasmid are camouflaged with folic acid ligands and luciferase NanoLuc-modified macrophage membranes. To conduct proof-of-concept research, this study employs a mouse model of retinoblastoma. In comparison to external blue light irradiation, the developed system enables an in situ bioluminescence-activated apoptotic pathway to inhibit tumor growth with greater therapeutic efficacy, resulting in a significant reduction in ocular tumor size. Furthermore, unlike external blue light irradiation, which causes retinal damage and corneal neovascularization, the camouflage nanoparticle-based optogenetic system maintains retinal structural integrity while avoiding corneal neovascularization.

[1]  Jiesi Luo,et al.  Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment , 2022, Journal of Nanobiotechnology.

[2]  Ronnie H. Fang,et al.  Neuronal Cellular Nanosponges for Effective Detoxification of Neurotoxins. , 2022, ACS nano.

[3]  Chunying Chen,et al.  Penetrating Macrophage-Based Nanoformulation for Periodontitis Treatment. , 2022, ACS nano.

[4]  J. Peça,et al.  Efficient spatially targeted gene editing using a near-infrared activatable protein-conjugated nanoparticle for brain applications , 2022, Nature Communications.

[5]  Yoshihiro Shimizu,et al.  A red light–responsive photoswitch for deep tissue optogenetics , 2022, Nature Biotechnology.

[6]  Weiwen Zhang,et al.  Light-Sensitive Lactococcus lactis for Microbe-Gut-Brain Axis Regulating via Upconversion Optogenetic Micro-Nano System. , 2022, ACS nano.

[7]  Yang Sun,et al.  Advances in Ophthalmic Optogenetics: Approaches and Applications , 2022, Biomolecules.

[8]  Haifeng Ye,et al.  A small and highly sensitive red/far-red optogenetic switch for applications in mammals , 2021, Nature Biotechnology.

[9]  Zhengcheng Zhang,et al.  Near-infrared manipulation of multiple neuronal populations via trichromatic upconversion , 2021, Nature Communications.

[10]  Xiaotu Ma,et al.  Biomimetic Nanoparticles Carrying a Repolarization Agent of Tumor-Associated Macrophages for Remodeling of the Inflammatory Microenvironment Following Photothermal Therapy. , 2021, ACS nano.

[11]  Yang Sun,et al.  Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model , 2021, Translational vision science & technology.

[12]  B. Savoldo,et al.  GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision , 2020, Nature Cancer.

[13]  Haifeng Ye,et al.  A non-invasive far-red light-induced split-Cre recombinase system for controllable genome engineering in mice , 2020, Nature Communications.

[14]  Yuan Ping,et al.  Engineering a far-red light–activated split-Cas9 system for remote-controlled genome editing of internal organs and tumors , 2020, Science Advances.

[15]  Yang Sun,et al.  Optogenetic stimulation of phosphoinositides reveals a critical role of primary cilia in eye pressure regulation , 2020, Science Advances.

[16]  M. Gomez-Ramirez,et al.  The BioLuminescent‐OptoGenetic in vivo response to coelenterazine is proportional, sensitive, and specific in neocortex , 2020, Journal of neuroscience research.

[17]  Xiaomin Zhang,et al.  Blue light-triggered optogenetic system for treating uveal melanoma , 2019, Oncogene.

[18]  A. Inutsuka,et al.  Visualization of a blue light transmission area in living animals using light-induced nuclear translocation of fluorescent proteins. , 2019, Biochemical and biophysical research communications.

[19]  Ling Wei,et al.  Improved trafficking and expression of luminopsins for more efficient optical and pharmacological control of neuronal activity , 2019, Journal of neuroscience research.

[20]  Won Do Heo,et al.  Optogenetic activation of intracellular antibodies for direct modulation of endogenous proteins , 2019, Nature Methods.

[21]  Ying Zhang,et al.  Sequentially Site-Specific Delivery of Apoptotic Protein and Tumor-Suppressor Gene for Combination Cancer Therapy. , 2019, Small.

[22]  Yan Zhang,et al.  An Upconversion Nanoparticle Enables Near Infrared-Optogenetic Manipulation of the Caenorhabditis elegans Motor Circuit. , 2019, ACS nano.

[23]  J. Kim,et al.  Noninvasive optical activation of Flp recombinase for genetic manipulation in deep mouse brain regions , 2019, Nature Communications.

[24]  Wentao Dai,et al.  Route to Rheumatoid Arthritis by Macrophage-Derived Microvesicle-Coated Nanoparticles. , 2018, Nano letters.

[25]  Xu Zhen,et al.  Cell Membrane Coated Semiconducting Polymer Nanoparticles for Enhanced Multimodal Cancer Phototheranostics. , 2018, ACS nano.

[26]  Haifeng Dong,et al.  Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma. , 2018, ACS nano.

[27]  X. Jing,et al.  Light-Activatable Red Blood Cell Membrane-Camouflaged Dimeric Prodrug Nanoparticles for Synergistic Photodynamic/Chemotherapy. , 2018, ACS nano.

[28]  Ronnie H. Fang,et al.  Nanoparticle Functionalization with Platelet Membrane Enables Multifactored Biological Targeting and Detection of Atherosclerosis. , 2017, ACS nano.

[29]  Xiaoqun Gong,et al.  Near-Infrared Light Triggered Upconversion Optogenetic Nanosystem for Cancer Therapy. , 2017, ACS nano.

[30]  Keitaro Yoshimoto,et al.  CRISPR–Cas9-based photoactivatable transcription systems to induce neuronal differentiation , 2017, Nature Methods.

[31]  S. Boddu,et al.  Folate Decorated Nanomicelles Loaded with a Potent Curcumin Analogue for Targeting Retinoblastoma , 2017, Pharmaceutics.

[32]  C. Lüscher,et al.  Temporally precise labeling and control of neuromodulatory circuits in the mammalian brain , 2017, Nature Methods.

[33]  Bryan C Dickinson,et al.  Evolution of a split RNA polymerase as a versatile biosensor platform. , 2017, Nature chemical biology.

[34]  M. Yazawa,et al.  A photoactivatable Cre-loxP recombination system for optogenetic genome engineering. , 2016, Nature chemical biology.

[35]  Haijun Yu,et al.  Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer. , 2016, ACS nano.

[36]  H. Janovjak,et al.  A Phytochrome Sensory Domain Permits Receptor Activation by Red Light. , 2016, Angewandte Chemie.

[37]  V. Verkhusha,et al.  An optogenetic system based on bacterial phytochrome controllable with near-infrared light , 2016, Nature Methods.

[38]  D. Norren,et al.  Light damage to the retina: an historical approach , 2016, Eye.

[39]  Wei Fan,et al.  Dye-Sensitized Core/Active Shell Upconversion Nanoparticles for Optogenetics and Bioimaging Applications. , 2016, ACS nano.

[40]  George J Augustine,et al.  Luminopsins integrate opto- and chemogenetics by using physical and biological light sources for opsin activation , 2016, Proceedings of the National Academy of Sciences.

[41]  E. Pavlidou,et al.  Anterior Segment Seeding in Eyes With Retinoblastoma Failing to Respond to Intraophthalmic Artery Chemotherapy. , 2015, JAMA ophthalmology.

[42]  J. Leblond,et al.  Switchable Lipids: Conformational Change for Fast pH-Triggered Cytoplasmic Delivery. , 2015, Angewandte Chemie.

[43]  Yuta Nihongaki,et al.  Photoactivatable CRISPR-Cas9 for optogenetic genome editing , 2015, Nature Biotechnology.

[44]  P. Prasad,et al.  Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics , 2014, Chemical reviews.

[45]  C. Shields,et al.  Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results. , 2014, JAMA ophthalmology.

[46]  Stefan R. Pulver,et al.  Independent Optical Excitation of Distinct Neural Populations , 2014, Nature Methods.

[47]  F. Munier,et al.  Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications , 2012, British Journal of Ophthalmology.

[48]  J. Massagué,et al.  Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. , 2011, Cancer cell.

[49]  Edward S Boyden,et al.  Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[50]  Maria Valéria Schmidt Goffi-Gomez,et al.  Evaluation of ototoxicity in children treated for retinoblastoma: preliminary results of a systematic audiological evaluation , 2011, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[51]  Young Sun,et al.  p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis , 2010, Oncogene.

[52]  N. Sheibani,et al.  Retinal light toxicity , 2011, Eye.

[53]  Christopher A. Voigt,et al.  Spatiotemporal Control of Cell Signalling Using A Light-Switchable Protein Interaction , 2009, Nature.

[54]  Douglas S Kim,et al.  Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration , 2008, Nature Neuroscience.

[55]  M. Zhong,et al.  Anionic LPD complexes for gene delivery to macrophage: Preparation, characterization and transfection in vitro , 2008 .

[56]  D. Burgess,et al.  Anionic liposomal delivery system for DNA transfection , 2004, The AAPS Journal.

[57]  H. Karanth,et al.  pH‐Sensitive liposomes‐principle and application in cancer therapy , 2007, The Journal of pharmacy and pharmacology.

[58]  A. Mitra,et al.  Identification and functional characterization of riboflavin transporter in human-derived retinoblastoma cell line (Y-79): mechanisms of cellular uptake and translocation. , 2005, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[59]  E. Huq,et al.  A light-switchable gene promoter system , 2002, Nature Biotechnology.

[60]  R. Weissleder.  A clearer vision for in vivo imaging , 2001, Nature Biotechnology.